title: What is the drug of choice for the acute termination of paroxysmal supraventricular tachycardia: verapamil, adenosine triphosphate, or adenosine?
authors.affiliation: Department of Cardiology, Tel Aviv-Elias Sourasky Medical Center, Israel.
authors.forename: B
authors.initials: B
authors.lastname: Belhassen
authors.forename: S
authors.initials: S
authors.lastname: Viskin
mesh_terms: D000241:Adenosine / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D000255:Adenosine Triphosphate / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D000328:Adult; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D002648:Child; D002986:Clinical Trials as Topic; D016527:Drug Costs; D004361:Drug Tolerance; D004526:Efficiency; D006801:Humans; D007223:Infant; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy*; D013617:Tachycardia, Supraventricular / Q000188:drug therapy*; D013997:Time Factors; D014700:Verapamil / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*
chemical_list: D000255:Adenosine Triphosphate; D014700:Verapamil; D000241:Adenosine